Concentric Medical, a provider of clot removal devices in ischemic stroke patients, has received CE mark for the full line of DAC Neurovascular Catheters.
CE mark was granted allowing the DAC family of distal access catheters to be used for the removal/aspiration of fresh, soft emboli and thrombi from vessels in the arterial system, including the neurovasculature.
Concentric Medical said that with the approval, the full range of DAC catheters may be utilised for aspirating and removing thrombus from the neurovasculature.
The DAC catheters continue to provide distal access and support in tortuous anatomy commonly encountered in stroke and other neurovascular procedures. The DAC family of catheters offers the broadest range of diameters and lengths, providing physicians more options and the ability to tailor their use of the device.
Concentric Medical added that the original DAC catheter was launched in mid 2008 as a distal access, support and delivery device for use in Merci Retriever procedures. The original product quickly gained favor in both Merci procedures and general neurovascular procedures.
The DAC catheter family was extended to include 7 different diameters and lengths in 2009. Also in 2009, the DAC family received FDA clearance for aspirating fresh, soft emboli and thrombi from vessels in the arterial system.
Maria Sainz, president and CEO of Concentric Medical, said: “The CE mark for this aspiration indication, is an important milestone as it further positions Concentric Medical as the company with the broadest acute ischemic stroke device options for physicians and patients.”
Thomas Liebig, interventional neuroradiologist at the Klinikum Rechts der Isar Technische Universitat Munchen, Germany, said: “I utilize the DAC in most of my interventional ischemic stroke procedures. It is an effective complement in not only gaining access and support for many devices, but also allows me to aspirate closer to the clot, to enhance clot retrieval for many patients.”